Evidence map›Paper›PMID 24975833›Full record

ReviewInternational immunopharmacology2014

Regulatory tone and mucosal immunity in asthma.

Timothy J Chapman, Steve N Georas

Abstract readReview
In one paragraph

Review in International immunopharmacology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Timothy J ChapmanDivision of Pulmonary and Critical Care Medicine, Department of Medicine, University of Rochester Medical Center, Rochester, NY 14610, United States.
Steve N GeorasDivision of Pulmonary and Critical Care Medicine, Department of Medicine, University of Rochester Medical Center, Rochester, NY 14610, United States. Electronic address: steve_georas@urmc.rochester.edu.

Funding

VISUAL INDICES OF NEUROTOXICITYP30ES001247 · NIEHS · UNIVERSITY OF ROCHESTER · PI B Paige Lawrence · 1985 to 2026
$42.8M
MULTIDISCIPLINARY TRAINING IN PULMONARY RESEARCHT32HL066988 · NHLBI · UNIVERSITY OF ROCHESTER · PI GEORAS, STEVE N, O'REILLY, MICHAEL A · 2001 to 2021
$8.1M
LPA and Edg Receptors in the Pulmonary Immune ResposeR01HL071933 · NHLBI · UNIVERSITY OF ROCHESTER · PI GEORAS, STEVE N · 2004 to 2013
$3.1M
Mechanisms of Endotoxin-induced Breakdown of Tolerance in the LungF32HL110718 · NHLBI · UNIVERSITY OF ROCHESTER · PI CHAPMAN, TIMOTHY J. · 2011 to 2013
$102k
NHLBI NIH HHS F32 HL110718NHLBI NIH HHS NIH F32 HL110718-01NHLBI NIH HHS NIH R01 HL071933NHLBI NIH HHS R01 HL071933NHLBI NIH HHS T32 HL066988NIEHS NIH HHS P30 ES001247
6 · The paper itself

Abstract

The lung is constantly exposed to a variety of inhaled foreign antigens, many of which are harmless to the body. Therefore, the mucosal immune system must not only have the capacity to distinguish self from non-self, but also harmless versus dangerous non-self. To address this, mucosal immune cells establish an anti-inflammatory steady state in the lung that must be overcome by inflammatory signals in order to mount an effector immune response. In the case of inhaled allergens, the false detection of dangerous non-self results in inappropriate immune activation and eventual allergic asthma. Both basic and clinical studies suggest that the balance between tolerogenic and inflammatory immune responses is a key feature in the outcome of health or disease. This review is focused on what we term 'regulatory tone': the immunosuppressive environment in the lung that must be overcome to induce inflammatory responses. We will summarize the current literature on this topic, with a particular focus on the role of regulatory T cells in preventing allergic disease of the lung. We propose that inter-individual differences in regulatory tone have the potential to not only establish the threshold for immune activation in the lung, but also shape the quality of resulting effector responses following tolerance breakdown.

Indexed as

AllergensAnimalsAsthmaDendritic CellsHumansImmune ToleranceImmunity, MucosalImmunologic MemoryModels, ImmunologicalT-Lymphocytes, RegulatoryAllergensAsthmaDendritic cellsLate-onset asthmaRegulatory T cellsRegulatory tone

Identifiers

PMID24975833
PMCPMC4253865

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.